BAKER BROS. ADVISORS LP
SEC CIK 1263508 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CELC | Celcuity Inc. | Former 10% owner | 4.37M | — | $317.75M | 1 | 2026-07-14 | 2026-07-14 |
| INCY | Incyte | Dir, 10% | 28.21M | — | — | 6 | 2021-09-30 | 2026-06-30 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Dir | 1.95M | $22.52M | — | 2 | 2023-12-13 | 2026-06-17 |
| ONC | BeOne Medicines Ltd. | Dir, 10% | 161.6K | — | $262.0K | 3 | 2024-06-05 | 2026-06-11 |
| DNLI | Denali Therapeutics Inc. | Dir | 3.42M | — | — | 2 | 2025-06-03 | 2026-06-03 |
| KNSA | Kiniksa Pharmaceuticals International, plc | Dir | 2.74M | — | — | 1 | 2026-05-29 | 2026-05-29 |
| ACAD | ACADIA PHARMACEUTICALS INC | Dir, 10% | 39.38M | — | — | 3 | 2022-06-07 | 2026-05-29 |
| BCYC | BICYCLE THERAPEUTICS PLC | Dir, 10% | 918.5K | — | — | 2 | 2024-04-18 | 2025-01-02 |
| TRDA | Entrada Therapeutics, Inc. | 10% | 355.6K | $713.2K | — | 2 | 2022-05-16 | 2022-05-20 |
| KOD | Kodiak Sciences Inc. | Dir, 10% | 1.16M | $26.42M | — | 4 | 2021-09-29 | 2022-01-27 |
Most active insiders at CELC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BAKER BROS. ADVISORS LP | Former 10% owner | — | $317.75M |
| 2 | Dalvey David | Dir | — | $7.42M |
| 3 | Buller Richard E | Dir | — | $2.40M |
| 4 | Murphy Polly A. | Dir | — | — |
| 5 | ROMP CHARLES R | Dir | — | — |
| 6 | Furcht Leo | Dir | — | — |
| 7 | Hahne Vicky | CFO | — | — |
| 8 | Laing Lance G. | CSO, Dir | — | — |
| 9 | NIGON RICHARD | Dir | — | — |
| 10 | Sullivan Brian F. | CEO, Dir | — | — |
Transactions 26
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-07-16 17:42 | 2026-07-14 | CELC | Celcuity Inc. | BAKER BROS. ADVISORS LP | Former 10% owner | S - Sale | $102.50 | -3.10M | 4.37M | -41% | -$317.75M |
| MI | 2026-07-02 16:31 | 2026-06-30 | INCY | Incyte | BAKER BROS. ADVISORS LP | Dir, 10% | A - Grant | $0.00 | +800 | 28.21M | +0.0% | $0 |
| DMI | 2026-06-18 16:03 | 2026-06-17 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | BAKER BROS. ADVISORS LP | Dir | A - Grant | $0.00 | +1,816 | 1.95M | +0.1% | $0 |
| MI | 2026-06-15 16:38 | 2026-06-11 | ONC | BeOne Medicines Ltd. | BAKER BROS. ADVISORS LP | Dir | A - Grant | $0.00 | +38.0K | 161.6K | +31% | $0 |
| DMI | 2026-06-10 16:41 | 2026-06-08 | INCY | Incyte | BAKER BROS. ADVISORS LP | Dir, 10% | A - Grant | $0.00 | +3,284 | 28.21M | +0.0% | $0 |
| DMI | 2026-06-05 16:28 | 2026-06-03 | DNLI | Denali Therapeutics Inc. | BAKER BROS. ADVISORS LP | Dir | A - Grant | $0.00 | +12.8K | 3.42M | +0.4% | $0 |
| DMI | 2026-06-02 16:32 | 2026-05-29 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Dir, 10% | A - Grant | $0.00 | +37.2K | 39.38M | +0.1% | $0 |
| DMI | 2026-06-02 16:30 | 2026-05-29 | KNSA | Kiniksa Pharmaceuticals International, plc | BAKER BROS. ADVISORS LP | Dir | A - Grant | $0.00 | +12.2K | 2.74M | +0.4% | $0 |
| MI | 2026-05-27 16:54 | 2026-05-22 | ONC | BeOne Medicines Ltd. | BAKER BROS. ADVISORS LP | Dir | S - Sale | $23.82 | -11.0K | 142.6K | -7% | -$262.0K |
| DMI | 2026-05-11 16:45 | 2026-05-08 | INCY | Incyte | BAKER BROS. ADVISORS LP | Dir, 10% | M - OptEx | $84.53 | +30.0K | 28.20M | +0.1% | +$2.54M |
| MI | 2026-04-02 16:10 | 2026-03-31 | INCY | Incyte | BAKER BROS. ADVISORS LP | Dir, 10% | A - Grant | $0.00 | +842 | 28.19M | +0.0% | $0 |
| DMI | 2025-06-05 | 2025-06-03 | DNLI | Denali Therapeutics Inc. | BAKER BROS. ADVISORS LP | Dir | A - Grant | $0.00 | +21.1K | 3.42M | +0.6% | $0 |
| DMI | 2025-01-06 | 2025-01-02 | BCYC | BICYCLE THERAPEUTICS PLC | BAKER BROS. ADVISORS LP | Dir, 10% | A - Grant | $0.00 | +8,800 | 918.5K | +1.0% | $0 |
| MI | 2024-10-02 | 2024-09-30 | INCY | Incyte | BAKER BROS. ADVISORS LP | Dir, 10% | A - Grant | $0.00 | +992 | 28.18M | +0.0% | $0 |
| DMI | 2024-06-07 | 2024-06-05 | ONC | BeOne Medicines Ltd. | BAKER BROS. ADVISORS LP | Dir, 10% | A - Grant | $0.00 | +65.4K | 126.1K | +108% | $0 |
| DMI | 2024-05-31 | 2024-05-29 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Dir, 10% | A - Grant | $0.00 | +37.5K | 39.35M | +0.1% | $0 |
| DMI | 2024-04-22 | 2024-04-18 | BCYC | BICYCLE THERAPEUTICS PLC | BAKER BROS. ADVISORS LP | Dir, 10% | A - Grant | $0.00 | +24.0K | 6.45M | +0.4% | $0 |
| MI | 2023-12-14 | 2023-12-13+ | MDGL | MADRIGAL PHARMACEUTICALS, INC. | BAKER BROS. ADVISORS LP | Dir | P - Purchase | $221.20 | +101.8K | 1.72M | +6% | +$22.52M |
| DMI | 2022-06-09 | 2022-06-07 | ACAD | ACADIA PHARMACEUTICALS INC | BAKER BROS. ADVISORS LP | Dir, 10% | A - Grant | $0.00 | +34.2K | 3.51M | +1.0% | $0 |
| MI | 2022-05-24 | 2022-05-20+ | TRDA | Entrada Therapeutics, Inc. | BAKER BROS. ADVISORS LP | 10% | P - Purchase | $5.82 | +48.5K | 355.6K | +16% | +$282.4K |
| MI | 2022-05-18 | 2022-05-16+ | TRDA | Entrada Therapeutics, Inc. | BAKER BROS. ADVISORS LP | 10% | P - Purchase | $5.99 | +71.9K | 354.7K | +25% | +$430.8K |
| MI | 2022-01-31 | 2022-01-27+ | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Dir, 10% | P - Purchase | $52.02 | +347.7K | 1.16M | +43% | +$18.08M |
| MI | 2021-10-04 | 2021-09-30 | INCY | Incyte | BAKER BROS. ADVISORS LP | Dir, 10% | A - Grant | $0.00 | +786 | 2.87M | +0.0% | $0 |
| DMI | 2021-10-01 | 2021-09-29 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Dir, 10% | M - OptEx | $0.01 | +150.0K | 13.44M | +1% | +$1,500 |
| DMI | 2021-10-01 | 2021-09-29 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Dir, 10% | F - Tax | $102.00 | -16 | 13.44M | -0.0% | -$1,632 |
| DI | 2021-10-01 | 2021-09-30 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Dir, 10% | P - Purchase | $95.83 | +86.9K | 13.53M | +0.6% | +$8.33M |
Purchase Sale Sale after option exercise All abbreviations